摘要:
Structure-guided drug design led to the identification of a class of spirocyclic ureas which potently inhibit human 11 beta-HSD1 in vitro. Lead compound 10j was shown to be orally bioavailable in three species, distributed into adipose tissue in the mouse, and its (R) isomer 10j2 was efficacious in a primate pharmacodynamic model. (C) 2009 Elsevier Ltd. All rights reserved.